We compared the expression of tumor immune response-related genes, such as CD8, CD4, PD-1, LAG3, A2aR, and TIM-3, between primary and metastatic sites using the same RNA seq data from the same sample set used in the current study14. The gene discussed is CD8A; the disease is neoplasm.